Rabies treatment safety study in kids halted early
NCT ID NCT05382650
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to check the safety of a rabies immune globulin shot (HyperRAB) in children who were treated after an animal bite. It included 35 kids aged 17 and under across several emergency rooms. The study was stopped early, so results are limited, but the goal was to see if the shot caused any side effects within a few days to a month.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRICS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Houston Methodist
Houston, Texas, 77030, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Pain lessons for preteens: could a classroom program reshape how children understand and respond to pain?
- Experimental antibody cocktail offers hope for rabies patients with no other options
- Teens' tonsil surgery pain: which painkiller works best?
- New antibody cocktail aims to stop rabies after multiple dog bites
- New care bundle slashes IV complications in kids at ER
- Hidden heart risk in kids with diabetes: new study investigates